跳至主要内容
临床试验/NCT04618146
NCT04618146Unknown不适用

Enhanced Recovery After Cesarean Section With Low Dose Intrathecal Morphine. A Prospective Randomized Controlled Study.

Minia University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2020年11月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
60
试验地点
1
主要终点
Pain postoperative

研究概览

简要总结

This study is designed to see the effect of low dose intrathecal morphine on promting enhanced recovery after cesarean delivery with early ambulation and reduction of hospital stay.

详细描述

Parturients showing for elective cesarean section will be randomized into 3 groups by a computer generated randomization list. Each randomization slip will be put in a sealed envelope until patient enrollment. Patients will be divided into Group C: control group, given intrathecal bupivacaine 12.5 mg. Group M25: intrathecal bupivacaine 12.5mg + morphine 25 microgram. Group M50: intrathecal bupivacaine 12.5mg + morphine 50 microgram.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
16 Years 至 45 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • Females scheduled for cesarean section
  • Age: 16-45 yrs.
  • Gestation age >38 weeks.

排除标准

  • Refusal to participate.
  • Significant cardiac, hepatic or renal dysfunction.
  • History of chronic itching problem, or hyperemesis during pregnancy

研究组 & 干预措施

Group C

Placebo Comparator

given intrathecal bupivacaine 12.5 mg.

干预措施: Bupivacaine Hydrochloride (Drug)

Group M25

Active Comparator

given intrathecal bupivacaine 12.5mg + morphine 25 microgram.

干预措施: Morphine Sulfate (Drug)

Group M25

Active Comparator

given intrathecal bupivacaine 12.5mg + morphine 25 microgram.

干预措施: Bupivacaine Hydrochloride (Drug)

Group M50

Active Comparator

given intrathecal bupivacaine 12.5mg + morphine 50 microgram.

干预措施: Morphine Sulfate (Drug)

Group M50

Active Comparator

given intrathecal bupivacaine 12.5mg + morphine 50 microgram.

干预措施: Bupivacaine Hydrochloride (Drug)

结局指标

主要结局

Pain postoperative

时间窗: 24 hours postoperatively

postoperative pain using Numerical pain score 0 no pain - 10 severe intolerable pain

次要结局

  • vomiting(24 hours postoperative)
  • respiratory depression(4 hours postoperative)
  • itching(24 hours postoperative)

研究者

发起方
Minia University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Sohair Adeeb

Principle investigator

Minia University

研究点 (1)

Loading locations...

相似试验